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Hospital deprescribing trials have demonstrated marginal increases in deprescribing activity that are 
not sustained beyond the trial period. The hospital deprescribing implementation framework (hDIF) 
links barriers and enablers of deprescribing in hospital with 44 potential intervention components. 
This study aimed to support geriatricians and pharmacists to select and characterise hDIF 
components according to affordability, practicability, effectiveness, acceptability, safety and equity 
(APEASE) to design a deprescribing intervention in the English hospital setting. 
 
Methods 
We convened a modified Nominal Group Technique with a panel of nine geriatricians and 
pharmacists representing five English hospitals. Panel members selected and characterised 
intervention components from the hDIF based on the APEASE criteria. We set a consensus threshold 
of 80% agreement per APEASE criterion in order for the intervention component to be included. 
 
Results 
The panel selected five intervention components supporting engagement with deprescribing: an 
organisational action plan to prioritise deprescribing; two training activities to address pharmacists’ 
beliefs about negative deprescribing consequences; restructuring pharmacists’ working patterns to 
facilitate their contribution to deprescribing decisions; sharing experiences of successfully engaging 
patients/family in deprescribing conversations to support others to do the same. A sixth component 
was selected to sustain engagement with deprescribing through measuring and sharing 
deprescribing activity achieved between teams. 
 
Conclusions 
Deprescribing interventions targeting geriatricians’ and pharmacists’ behaviour in the English 
hospital context should include the six characterised components. A component to sustain 
deprescribing activity is a notable omission from previously reported deprescribing interventions 
and may explain their failure to maintain efficacy beyond the short-term trial period. 
  




• Selection of intervention components to change deprescribing behaviour is context specific 
• Target audience selection of intervention components is feasible and provides contextual 
insight to underpin intervention design 
• This study provides six components for a deprescribing intervention targeting geriatricians' 
and pharmacists' behaviour 
  
Background 
Inappropriate medicines are associated with adverse outcomes including morbidity, mortality and 
hospitalisation[1]. Over 50% of older hospitalised patients are prescribed at least one potentially 
inappropriate medicine[1], however only 6% have any medicine deprescribed during their hospital 
admission[2].  
Geriatricians and pharmacists perceive deprescribing to align with their generalist roles and 
knowledge, however there are four main barriers and one enabler, described in figure 2, that require 
addressing to facilitate routine deprescribing within their practices[3]. A selection of 47 behaviour 
change techniques (BCTs) have been identified as potentially appropriate for addressing these 
barriers and enabler within the hospital deprescribing implementation framework (hDIF)[3]. BCTs 
should be selected from the hDIF for a deprescribing intervention according to contextual factors 
and affordability, practicability, effectiveness, acceptability, safety and equity (APEASE criteria)[4]. 
Historically, selection of BCTs for interventions has been researcher-led[5–7]. The limitation of this 
approach is that researchers lack contextual insight relative to the target audience. However, the 
target audience lack behavioural science expertise to make inform decisions about BCT selection. 
Given the importance of considering context when developing interventions[4], there is a need to 
formulate and test a strategy to support target audience selection of BCTs. 
This consensus study aimed to determine the feasibility of target audience selection of BCTs for 
deprescribing interventions. The study also aimed to select BCTs from the hDIF for a deprescribing 




We obtained ethical approval from the Faculty of Medicine and Health Sciences Research Ethics 
Committee, University of East Anglia (Reference: 2018/19-009). 
 
Design 
We convened a panel of senior geriatricians and pharmacists naïve to the hDIF to select and 
characterise BCTs for a hospital deprescribing intervention using a modified nominal group 
technique (NGT) in the two stages of an initial voting round and in person NGT[8]. A modified NGT 
was the most appropriate consensus method for the study objectives[8]. 
 
Participants 
We purposively sampled geriatricians and pharmacists from five teaching and district general 
hospitals across three English counties to represent a range of contexts. 
 
Recruitment 




To reduce burden on the panel, we initially appraised the 47 BCTs from the hDIF (figure 2) through 
discussions within the research team to remove any that were clearly inappropriate for the English 
hospital context. Our discussions were guided by the APEASE criteria[4]. We proposed removing 19 
BCTs and presented our rationale (appendix 1) to the study management group of geriatricians, 
pharmacists and patient/family representatives. 
 
Stage 1 Initial voting round 
Procedure 
We developed and distributed an online survey (appendix 2) to support the panel to appraise BCTs 
according to the APEASE criteria[4]. Plain English descriptions of the four barriers, one enabler and 
the 28 BCT formed the survey. The panel were promoted to appraise each BCT according to the 
APEASE criterion on a four-point Likert scale (strongly disagree to strongly agree). 
We piloted the online survey with geriatrician and pharmacist collaborators (n=3) who were not 




We reported descriptive statistics for the APEASE criteria across BCTs and a consensus threshold was 
set at 80% of panel members agreeing or strongly agreeing that a BCT met all six APEASE criteria[9]. 
BCTs meeting this threshold were accepted for the intervention and progressed to characterisation 
discussions in stage 2. We set a partial consensus threshold at 80% agreement that a BCT met at 
least three of APEASE criteria. In the absence of BCTs meeting the consensus threshold for a given 
barrier or enabler, all relevant partial consensus BCTs progressed to stage 2 for further consensus 
discussions. We excluded all other BCTs. 
 
Stage 2: In person NGT 
Procedure 
The aims of stage 2 were to facilitate: 
1. Discussion to achieve consensus to accept or reject partial consensus BCTs 
2. Discussion to characterise accepted BCTs for the deprescribing intervention 
 
We provided the panel with the stage 1 survey responses for each of the partial consensus BCTs. We 
facilitated one NGT cycle (silent generation, round robin, clarification, voting and discussion)[8] per 
BCT to reach panel consensus to accept or reject. The voting round and consensus threshold 
mirrored the online survey APEASE criteria appraisal. 
We then facilitated a further NGT cycle per accepted BCT for the panel to characterise them in terms 
of how they may be operationalised in the hospital setting. 
 
Analysis 
We analysed the voting in real time using the Turning Point platform®. We made handwritten notes 
of BCT characterisation statements generated which were refined and validated by the panel. 
 
Results 
We recruited nine geriatricians (n=4) and pharmacists (n=5), six were male and their mean (standard 
deviation) age was 40 (9) years. 
Full responses to the stage 1 online survey are provided in appendix 3. Figure 1 summarises BCTs 
proceeding through the study. 
  
 
Figure 1 Summary of behaviour change techniques proceeding through the study 
*Behaviour change technique (BCT) (social comparison) absent from the hDIF introduced by the 
panel to address the enabler of incentivisation of deprescribing 
**BCT (social comparison) selected and characterised twice (see figure 2)  
The panel reached consensus to accept three BCTs for inclusion in the deprescribing intervention at 
stage 1. A further three BCTs were accepted at stage 2. 
 
Stage 2: Face-to-face NGT 
NGT cycles for ‘Restructuring the physical environment’ and ‘Action planning’ resulted in consensus 
to accept. The practicality criterion for ‘Classical conditioning’ failed to achieve consensus. The panel 
suggested that the enabler of incentivisation may be addressed instead by “measuring, reporting 
and sharing levels of deprescribing achieved between team such as wards or hospitals”. This aligns 
with the BCT ‘social comparison’[10]. The panel reached consensus to accept this newly proposed 
BCT. 
The characterised BCTs are provided in figure 2. The panel operationalised the BCTs designed to 
address practitioners’ barrier of a misconception that patients and carers are resistant to 
deprescribing through a mentor. The two BCTs to address beliefs about negative deprescribing 
consequences were operationalised within one package delivered through online or face-to-face 
training. Whilst pharmacists attending geriatricians’ ward rounds was the desired characterisation 
for the BCT, this was deemed unaffordable. Pharmacists attending 30 minute multi-disciplinary 
meetings was the operationalised BCT to address working patterns limiting time to support 
deprescribing. Designating a geriatrician and pharmacist to engage with senior managers such as the 
medical and nursing directors to develop an organisational-level action plan was the operationalised 
BCT to address the perception of deprescribing being a low hospital priority. 
For the enabler of incentivisation, the panel suggested focussing the BCT on the proportion of 
patients screened for deprescribing opportunities between hospital wards, hospitals and regions.
 
Figure 2 Hospital deprescribing implementation framework (hDIF)[3] and the six behaviour change techniques (BCTs) selected and characterised for 
operationalisation in a hospital deprescribing intervention by the panel.
Discussion 
This study demonstrates a feasible approach for operationalising the hDIF for individual health 
contexts. For the English hospital context, a deprescribing intervention should include organisational 
commitment through an action plan and restructuring of pharmacists’ working patterns. Training is 
also required to allay concerns about deprescribing and mentorship to address misconceptions that 
patients/carers are resistant to deprescribing. Benchmarking between teams will support 
reinforcement of deprescribing activity. 
Five of the six selected BCTs recognise that proactive deprescribing is not routine practice[2] and 
align with facilitating initiation of activity. The BCT ‘social comparison’ to incentivise deprescribing 
supports sustainment of activity. This aligns with calls for interventions to be developed with a view 
to sustainment beyond the reactivity bias generated by the trial involvement[11]. This configuration 
departs from previously reported interventions that have focussed on initiating activity, such as 
providing tools to identify inappropriate medicines. This may offer an explanation for interventions 
not maintaining efficacy beyond the short term trial period[12]. 
‘Action planning’ at the organisational level establishes deprescribing as a priority through specifying 
where, when and how the hospital’s deprescribing goals will be achieved. This formal planning and 
endorsing new ways of working has demonstrated increased probability of implementation[13]. 
The panel’s characterisation of ‘restructuring the physical environment’ aligns with previous 
successes in achieving behaviour change in the hospital setting by enabling pharmacists to attend 
multidisciplinary antimicrobial stewardship rounds[14]. The two BCTs selected to enable pharmacists 
to assume this supportive role by addressing beliefs about negative deprescribing consequences 
recognise that they have appropriate knowledge regarding the risks and benefits of deprescribing 
and not deprescribing. The ‘salience of consequences’ and ‘pros and cons’ BCTs therefore require 
pharmacists to appraise and evaluate deprescribing opportunities through training[15]. 
Whilst there is evidence contrasting the misconception that patients/family are resistant to 
deprescribing[16], provision of this knowledge was not selected by the panel. ‘Social comparison’ 
through observing a peer successfully agreeing deprescribing with a patient/family was rated more 
favourably in terms of effectiveness. This BCT aligns with the substantial body of literature 
demonstrating mentorship as a more effective method of knowledge translation than knowledge 
provision[17]. 
Geriatricians and pharmacists without expertise in behavioural science selecting BCTs for an 
intervention targeting their own behaviour is a key strength of this study. The panel’s decision to 
address the enabler of incentivising deprescribing with a BCT not offered by the hDIF is a limitation. 
This may be a result of the plain English statements for the BCTs offered by the hDIF describing them 
as rewards for deprescribing at the practitioner level, rather than at the organisational level, which 
may have been more acceptable. Our decision to initially appraise the BCTs and exclude 19 during 
this process is a potential limitation given that not all BCTs were therefore appraised by the panel. 




Hospital deprescribing interventions should attend both to the barriers of initiating deprescribing 
activity and strategies to sustain. The target audience of a deprescribing behaviour change 
intervention have been successfully supported to use the hDIF to select and characterise six 
intervention components to address the barriers and enabler to deprescribing in hospital. 
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